Literature DB >> 33215860

Comprehensive analysis of partial epithelial mesenchymal transition-related genes in hepatocellular carcinoma.

Yu Lei1, Wei Yan1, Zhuoying Lin1, Jingmei Liu1, Dean Tian1, Ping Han1.   

Abstract

Increasing evidence has revealed that cancer cells undergoing an intermediate state, partial epithelial mesenchymal transition (p-EMT), tend to metastasize rather than complete EMT. We performed a comprehensive analysis of E-cadherin and 25 p-EMT-related genes in HCC to explore the roles and regulatory mechanisms of them in HCC. We analysed E-cadherin and 25 p-EMT-related genes in HCC and constructed an mRNA-miRNA-lncRNA ceRNA subnetwork containing p-EMT-related genes by bioinformatic approaches. IHC was used to identify the protein expression of key p-EMT-related genes, P4HA2, ITGA5, MMP9, MT1X and SPP1. Complete EMT is not necessary for HCC progression. Overexpression of P4HA2, ITGA5, MMP9, SPP1 and down-regulation of MT1X were found in HCC tissues, which were significantly associated with poor prognosis of HCC patients. By means of stepwise reverse prediction and validation from mRNA to lncRNA, an mRNA-miRNA-lncRNA ceRNA subnetwork correlated with HCC prognosis was identified by expression and survival analysis. This study implied that key p-EMT-related genes P4HA2, ITGA5, MMP9, MT1X, SPP1 could be prognostic biomarkers and potential targets of therapy for HCC patients. We constructed an mRNA-miRNA-lncRNA subnetwork containing p-EMT-related genes successfully, among which each component might be utilized as a prognostic biomarker of HCC.
© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Entities:  

Keywords:  competing endogenous RNA; hepatocellular carcinoma; partial epithelial mesenchymal transition; prognosis

Year:  2020        PMID: 33215860      PMCID: PMC7810929          DOI: 10.1111/jcmm.16099

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  49 in total

Review 1.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; María Reig; Jordi Bruix
Journal:  Lancet       Date:  2018-01-05       Impact factor: 79.321

2.  Metallothionein 1 family profiling identifies MT1X as a tumor suppressor involved in the progression and metastastatic capacity of hepatocellular carcinoma.

Authors:  Zhikun Liu; Qianwei Ye; Lingjiao Wu; Feng Gao; Haiyang Xie; Lin Zhou; Shusen Zheng; Xiao Xu
Journal:  Mol Carcinog       Date:  2018-08-26       Impact factor: 4.784

3.  BVES inhibition triggers epithelial-mesenchymal transition in human hepatocellular carcinoma.

Authors:  Ping Han; Yu Fu; Min Luo; Jiayi He; Jingmei Liu; Jiazhi Liao; Dean Tian; Wei Yan
Journal:  Dig Dis Sci       Date:  2014-01-18       Impact factor: 3.199

4.  Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.

Authors:  G X Feng; J Li; Z Yang; S Q Zhang; Y X Liu; W Y Zhang; L H Ye; X D Zhang
Journal:  Oncogene       Date:  2017-08-28       Impact factor: 9.867

Review 5.  Involvement of partial EMT in cancer progression.

Authors:  Masao Saitoh
Journal:  J Biochem       Date:  2018-10-01       Impact factor: 3.387

6.  [Expression of the integrin alpha 5 subunit in hepatocellular carcinoma].

Authors:  M Yao; X Zhou; X Zha
Journal:  Zhonghua Yi Xue Za Zhi       Date:  1997-05

Review 7.  Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe?

Authors:  Maren Diepenbruck; Gerhard Christofori
Journal:  Curr Opin Cell Biol       Date:  2016-06-29       Impact factor: 8.382

8.  STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4.

Authors:  Hui Wang; Xisong Huo; Xin-Rong Yang; Jia He; Lijun Cheng; Na Wang; Xuan Deng; Haojie Jin; Ning Wang; Cun Wang; Fangyu Zhao; Jingyuan Fang; Ming Yao; Jia Fan; Wenxin Qin
Journal:  Mol Cancer       Date:  2017-08-14       Impact factor: 27.401

9.  A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential.

Authors:  Emily Gobin; Kayla Bagwell; John Wagner; David Mysona; Sharmila Sandirasegarane; Nathan Smith; Shan Bai; Ashok Sharma; Robert Schleifer; Jin-Xiong She
Journal:  BMC Cancer       Date:  2019-06-14       Impact factor: 4.430

10.  LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro.

Authors:  Yin Tang; Ping Yang; Yunfeng Zhu; Yong Su
Journal:  Thorac Cancer       Date:  2019-11-19       Impact factor: 3.500

View more
  10 in total

1.  Familiarity Breeds Strategy: In Silico Untangling of the Molecular Complexity on Course of Autoimmune Liver Disease-to-Hepatocellular Carcinoma Transition Predicts Novel Transcriptional Signatures.

Authors:  Soumyadeep Mukherjee; Arpita Kar; Najma Khatun; Puja Datta; Avik Biswas; Subhasis Barik
Journal:  Cells       Date:  2021-07-29       Impact factor: 6.600

2.  Exploring potential targets of Actinidia chinensis Planch root against hepatocellular carcinoma based on network pharmacology and molecular docking and development and verification of immune-associated prognosis features for hepatocellular carcinoma.

Authors:  Meilin Qu; Tao Han; Xiaoquan Chen; Qingqing Sun; Qing Li; Mingfang Zhao
Journal:  J Gastrointest Oncol       Date:  2022-06

Review 3.  Current perspectives on exosomes in the diagnosis and treatment of hepatocellular carcinoma (review).

Authors:  Dongdong Xue; Jingzhao Han; Yifan Liu; Hongfang Tuo; Yanhui Peng
Journal:  Cancer Biol Ther       Date:  2021-04-13       Impact factor: 4.742

4.  Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma.

Authors:  Haisu Tao; Yuxin Zhang; Tong Yuan; Jiang Li; Junjie Liu; Yixiao Xiong; Jinghan Zhu; Zhiyong Huang; Ping Wang; Huifang Liang; Erlei Zhang
Journal:  Aging (Albany NY)       Date:  2022-02-11       Impact factor: 5.682

5.  Comprehensive Integrated Single-Cell Whole Transcriptome Analysis Revealed the p-EMT Tumor Cells-CAFs Communication in Oral Squamous Cell Carcinoma.

Authors:  Nam Cong-Nhat Huynh; Tze-Ta Huang; Chi Thi-Kim Nguyen; Fang-Kuei Lin
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

6.  GIV is a promising novel poor prognostic factor in liver hepatocellular carcinoma.

Authors:  Zhenzhen Zou; Yibin Sun; Lin Wang; Sai Ma; Chunrong Sun; Yu Zhou; Guorong Yang
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

7.  Expression pattern of non-coding RNAs in non-functioning pituitary adenoma.

Authors:  Soudeh Ghafouri-Fard; Arash Safarzadeh; Mehdi Akhavan-Bahabadi; Bashdar Mahmud Hussen; Mohammad Taheri; Nader Akbari Dilmaghani
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

8.  Single-cell transcriptome reveals cellular hierarchies and guides p-EMT-targeted trial in skull base chordoma.

Authors:  Qilin Zhang; Lijiang Fei; Rui Han; Ruofan Huang; Yongfei Wang; Hong Chen; Boyuan Yao; Nidan Qiao; Zhe Wang; Zengyi Ma; Zhao Ye; Yichao Zhang; Weiwei Wang; Ye Wang; Lin Kong; Xuefei Shou; Xiaoyun Cao; Xiang Zhou; Ming Shen; Haixia Cheng; Zhenwei Yao; Chao Zhang; Guoji Guo; Yao Zhao
Journal:  Cell Discov       Date:  2022-09-20       Impact factor: 38.079

9.  Comprehensive analysis of partial epithelial mesenchymal transition-related genes in hepatocellular carcinoma.

Authors:  Yu Lei; Wei Yan; Zhuoying Lin; Jingmei Liu; Dean Tian; Ping Han
Journal:  J Cell Mol Med       Date:  2020-11-20       Impact factor: 5.310

10.  lncRNA/miR-29c-Mediated High Expression of LOX Can Influence the Immune Status and Chemosensitivity and Can Forecast the Poor Prognosis of Gastric Cancer.

Authors:  Aitao Nai; Huihui Zeng; Qiong Wu; Zirui He; Shuwen Zeng; Shoaib Bashir; Feng Ma; Jie He; Wei Wan; Meng Xu
Journal:  Front Cell Dev Biol       Date:  2022-01-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.